Hyland’s Score Points Asking To Dismiss Class Action, But Loses Ruling
Executive Summary
Hyland’s fails to convince a federal court to dismiss nationwide class claims alleging false advertising of its baby products, but the judge says the two women alleging the firm made false claims about its homeopathic formulas have a “high hurdle” to demonstrate a nationwide class action.
You may also be interested in...
Hyland's Argues Class Action Trips On State Laws Despite 'Artful Pleading'
Hyland’s says a class action complaint alleging deceptive business practices and false advertising for its baby products is not suitable to represent a class of consumers outside New York. But the plaintiffs argue that the issue over class suitability should be considered during the certification stage.
Homeopathic Advertising Offers Slim Target For FTC Scrutiny – Industry
OTC homeopathic brands rely largely on word-of-mouth advertising from consumers’ friends and family members about their products’ safety and efficacy, stakeholders say at an FTC workshop. Consumers trust homeopathic OTCs even if they don’t understand products’ formulations, they say.
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.